Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amos Baruch

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Molecular Pharmacology|August 21, 2015
Critical Cysteine Residues in Both the Calcium-Sensing Receptor and the Allosteric Activator AMG 416 Underlie the Mechanism of ActionShawn T Alexander, Thomas Hunter, Sarah Walter, et al.
Molecular Cell|April 22, 2004
A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factorBrigitte Goulet, Amos Baruch, Nam-Sung Moon, et al.
The Journal of Biological Chemistry|August 3, 2002
Molecular cloning, functional expression, and tissue distribution of a novel human gap junction-forming protein, connexin-31.9. Interaction with zona occludens protein-1Peter A Nielsen, Derek L Beahm, Ben N G Giepmans, et al.
Bioanalysis|September 14, 2016
Characterization of IL-17AA and IL-17FF in rheumatoid arthritis and multiple sclerosisCheryl Schofield, Saloumeh K Fischer, Michael J Townsend, et al.
Molecular Biology of the Cell|June 17, 2003
Lens connexins alpha3Cx46 and alpha8Cx50 interact with zonula occludens protein-1 (ZO-1)Peter A Nielsen, Amos Baruch, Valery I Shestopalov, et al.
Mabs|September 13, 2017
Preclinical pharmacokinetic characterization of an adipose tissue-targeting monoclonal antibody in obese and non-obese animalsSharmila Rajan, Danielle Mandikian, Amos Baruch, et al.
The AAPS Journal|April 1, 2015
Modeling and Simulation to Support Phase 2 Dose Selection for RG7652, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9Nageshwar R Budha, Maya Leabman, Jin Y Jin, et al.
Science (New York, N.Y.)|December 10, 2002
A role for the protease falcipain 1 in host cell invasion by the human malaria parasiteDoron C Greenbaum, Amos Baruch, Munira Grainger, et al.
Plos One|October 30, 2019
Sustained activity of novel THIOMAB antibody-antibiotic conjugate against Staphylococcus aureus in a mouse model: Longitudinal pharmacodynamic assessment by bioluminescence imagingChenguang Zhou, Hao Cai, Amos Baruch, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 23, 2014
Combined administration of RG7652, a recombinant human monoclonal antibody against PCSK9, and atorvastatin does not result in reduction of immune functionThomas R Gelzleichter, Wendy Halpern, Roy Erwin, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Molecular Pharmacology|August 21, 2015
Critical Cysteine Residues in Both the Calcium-Sensing Receptor and the Allosteric Activator AMG 416 Underlie the Mechanism of ActionShawn T Alexander, Thomas Hunter, Sarah Walter, et al.
Molecular Cell|April 22, 2004
A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factorBrigitte Goulet, Amos Baruch, Nam-Sung Moon, et al.
The Journal of Biological Chemistry|August 3, 2002
Molecular cloning, functional expression, and tissue distribution of a novel human gap junction-forming protein, connexin-31.9. Interaction with zona occludens protein-1Peter A Nielsen, Derek L Beahm, Ben N G Giepmans, et al.
Bioanalysis|September 14, 2016
Characterization of IL-17AA and IL-17FF in rheumatoid arthritis and multiple sclerosisCheryl Schofield, Saloumeh K Fischer, Michael J Townsend, et al.
Molecular Biology of the Cell|June 17, 2003
Lens connexins alpha3Cx46 and alpha8Cx50 interact with zonula occludens protein-1 (ZO-1)Peter A Nielsen, Amos Baruch, Valery I Shestopalov, et al.
Mabs|September 13, 2017
Preclinical pharmacokinetic characterization of an adipose tissue-targeting monoclonal antibody in obese and non-obese animalsSharmila Rajan, Danielle Mandikian, Amos Baruch, et al.
The AAPS Journal|April 1, 2015
Modeling and Simulation to Support Phase 2 Dose Selection for RG7652, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9Nageshwar R Budha, Maya Leabman, Jin Y Jin, et al.
Science (New York, N.Y.)|December 10, 2002
A role for the protease falcipain 1 in host cell invasion by the human malaria parasiteDoron C Greenbaum, Amos Baruch, Munira Grainger, et al.
Plos One|October 30, 2019
Sustained activity of novel THIOMAB antibody-antibiotic conjugate against Staphylococcus aureus in a mouse model: Longitudinal pharmacodynamic assessment by bioluminescence imagingChenguang Zhou, Hao Cai, Amos Baruch, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 23, 2014
Combined administration of RG7652, a recombinant human monoclonal antibody against PCSK9, and atorvastatin does not result in reduction of immune functionThomas R Gelzleichter, Wendy Halpern, Roy Erwin, et al.
Pageof 5